Status:
UNKNOWN
ProCaLung: Project on Cancer of the Lung
Lead Sponsor:
Jules Bordet Institute
Collaborating Sponsors:
Belgian Federal Public Service, Food Chain Safety and Environment
Belgian Cancer Registry
Conditions:
Locally Advanced Lung Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
ProCaLung is a national registry collecting radiation treatment parameters of patients having lung cancer that extends to mediastinal lymph nodes. The project includes a peer review activity. The pur...
Eligibility Criteria
Inclusion
- Histologically confirmed NSCLC only
- Locally advanced disease (Stage III) with positive mediastinal nodes
- PET/CT staged
- Curative intent radiotherapy
- Chemotherapy (ChT): Without, Sequential ChT - Radiotherapy (RT) (max 2 cycles), Concurrent (± induction ChT)
- Prescription dose ≥ 60 Gy (EQD2)
Exclusion
- Prior history of thoracic RT
- Malignant pleural effusion
- History of malignancy in the last 3 years, except basal-cell skin cancer and intra-epithelial neoplasia
- Progression after induction chemotherapy
- Use of concurrent targeted, immunomodulating or anti-angiogenic agents except if the patient is included in a clinical trial
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04726358
Start Date
October 1 2021
End Date
March 1 2025
Last Update
June 12 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
GZA Ziekenhuizen (campus Sint-Augustinus)
Antwerp, Belgium, 2610
2
Institut Jules Bordet
Brussels, Belgium, 1070
3
UZ Gent
Ghent, Belgium, 9000
4
AZ Sint-Maarten
Mechelen, Belgium, 2800